| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |